Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Square Pharmaceuticals
Pharmaceutical Preparation ManufacturingBangladesh
Last verified 26 days agosquarepharma.com.bd
Square Pharmaceuticals Ltd., headquartered in Dhaka, Bangladesh, is a leading player in the Pharmaceutical Preparation Manufacturing industry. Established in 1985, the company has grown to become one of the largest pharmaceutical manufacturers in Bangladesh, with a strong presence in both domestic and international markets.
Specialising in a diverse range of products, Square Pharmaceuticals offers high-quality formulations across various therapeutic categories, including antibiotics, analgesics, and cardiovascular medications. Their commitment to innovation and quality has earned them numerous accolades, solidifying their reputation as a trusted name in healthcare.
With a robust distribution network and a focus on research and development, Square Pharmaceuticals continues to enhance its market position, contributing significantly to the advancement of the pharmaceutical sector in Bangladesh and beyond.
20
DitchCarbon score
-22 vs industry average
Square Pharmaceuticals’s score of 20 is lower than 26% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Square Pharmaceuticals?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very Low
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
20202021202220232024202520262027
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Square Pharmaceuticals's reported carbon emissions
Square Pharmaceuticals, a pharmaceutical preparation manufacturing company headquartered in BD, reported approximately 59,705,000 kg CO2e in Scope 1 emissions and 4,387,000 kg CO2e in Scope 2 emissions for 2024. This emissions data is cascaded from its parent organization, Square Pharmaceuticals PLC. The company has not publicly disclosed its Scope 3 emissions. No specific carbon reduction targets or climate commitments for Square Pharmaceuticals are available at this time.
Assessing Square Pharmaceuticals as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Square Pharmaceuticals and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Square Pharmaceuticals’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Square Pharmaceuticals yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Square Pharmaceuticals26 days ago
20
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more